Cargando…

Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review

With the increase in bacterial resistance to antibiotics, more and more therapeutic failures are being reported worldwide. The market for antibiotics is now broken due to the high cost of developing new molecules. A promising solution to bacterial resistance is combined phage–antibiotic therapy, a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Diallo, Kevin, Dublanchet, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311689/
https://www.ncbi.nlm.nih.gov/pubmed/35884092
http://dx.doi.org/10.3390/antibiotics11070839
_version_ 1784753654463463424
author Diallo, Kevin
Dublanchet, Alain
author_facet Diallo, Kevin
Dublanchet, Alain
author_sort Diallo, Kevin
collection PubMed
description With the increase in bacterial resistance to antibiotics, more and more therapeutic failures are being reported worldwide. The market for antibiotics is now broken due to the high cost of developing new molecules. A promising solution to bacterial resistance is combined phage–antibiotic therapy, a century-old method that can potentiate existing antibiotics by prolonging or even restoring their activity against specific bacteria. The aim of this literature review was to provide an overview of different phage–antibiotic combinations and to describe the possible mechanisms of phage–antibiotic synergy.
format Online
Article
Text
id pubmed-9311689
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93116892022-07-26 Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review Diallo, Kevin Dublanchet, Alain Antibiotics (Basel) Review With the increase in bacterial resistance to antibiotics, more and more therapeutic failures are being reported worldwide. The market for antibiotics is now broken due to the high cost of developing new molecules. A promising solution to bacterial resistance is combined phage–antibiotic therapy, a century-old method that can potentiate existing antibiotics by prolonging or even restoring their activity against specific bacteria. The aim of this literature review was to provide an overview of different phage–antibiotic combinations and to describe the possible mechanisms of phage–antibiotic synergy. MDPI 2022-06-22 /pmc/articles/PMC9311689/ /pubmed/35884092 http://dx.doi.org/10.3390/antibiotics11070839 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Diallo, Kevin
Dublanchet, Alain
Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title_full Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title_fullStr Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title_full_unstemmed Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title_short Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
title_sort benefits of combined phage–antibiotic therapy for the control of antibiotic-resistant bacteria: a literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311689/
https://www.ncbi.nlm.nih.gov/pubmed/35884092
http://dx.doi.org/10.3390/antibiotics11070839
work_keys_str_mv AT diallokevin benefitsofcombinedphageantibiotictherapyforthecontrolofantibioticresistantbacteriaaliteraturereview
AT dublanchetalain benefitsofcombinedphageantibiotictherapyforthecontrolofantibioticresistantbacteriaaliteraturereview